These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8236823)

  • 21. [Steroid hormonal receptors, heat shock protein and p53 of endometrioid and clear cell cancers in different localization].
    Kedzia W; Spaczyński M
    Ginekol Pol; 2002 Aug; 73(8):685-90. PubMed ID: 12369295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
    Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
    Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance.
    Sivridis E; Giatromanolaki A; Koukourakis MI; Georgiou L; Anastasiadis P
    Histopathology; 2002 Jan; 40(1):92-100. PubMed ID: 11903603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of hPEBP4 negatively correlates with estrogen and progesterone receptors in endometrial carcinoma.
    Guo T; Li B; Gu C
    J BUON; 2013; 18(2):465-70. PubMed ID: 23818363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serous endometrial cancers that mimic endometrioid adenocarcinomas: a clinicopathologic and immunohistochemical study of a group of problematic cases.
    Darvishian F; Hummer AJ; Thaler HT; Bhargava R; Linkov I; Asher M; Soslow RA
    Am J Surg Pathol; 2004 Dec; 28(12):1568-78. PubMed ID: 15577675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.
    Sivridis E; Giatromanolaki A; Koukourakis M; Anastasiadis P
    Virchows Arch; 2001 May; 438(5):470-7. PubMed ID: 11407475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human telomerase P53 estrogen and progesterone receptor expression in endometrial carcinoma].
    Dong Y; Li T; Liang Y; Zou WZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 36(1):61-5. PubMed ID: 14970891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.
    Halperin R; Zehavi S; Habler L; Hadas E; Bukovsky I; Schneider D
    Eur J Gynaecol Oncol; 2001; 22(2):122-6. PubMed ID: 11446475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supervised clustering of immunohistochemical markers to distinguish atypical endometrial hyperplasia from grade 1 endometrial cancer.
    Laas E; Ballester M; Cortez A; Gonin J; Daraï E; Graesslin O
    Gynecol Oncol; 2014 May; 133(2):205-10. PubMed ID: 24556060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotypic features of dedifferentiated endometrial carcinoma - insights from BRG1/INI1-deficient tumours.
    Hoang LN; Lee YS; Karnezis AN; Tessier-Cloutier B; Almandani N; Coatham M; Gilks CB; Soslow RA; Stewart CJ; Köbel M; Lee CH
    Histopathology; 2016 Oct; 69(4):560-9. PubMed ID: 27101785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relationships between the molecular biomarkers and the clinicopathologic features and prognosis in endometrial carcinoma].
    Yao YY; Xu WZ; Wang Y; Shen DH; Wang JL; Wei LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 43(5):743-8. PubMed ID: 22008688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors.
    Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I
    Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical expression of heat shock protein 27, in normal hyperplastic and neoplastic endometrium: correlation with estrogen and progesterone receptor status, p53, pRb and proliferation associated indices (PCNA, MIB1).
    Zagorianakou N; Ioachim E; Mitselou A; Kitsou E; Zagorianakou P; Makrydimas G; Salmas M; Agnantis NJ
    Eur J Gynaecol Oncol; 2003; 24(3-4):299-304. PubMed ID: 12807244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of cerb B 2 expression with estrogen receptor and progesterone receptor and prognostic parameters in endometrial carcinomas.
    Gul AE; Keser SH; Barisik NO; Kandemir NO; Cakir C; Sensu S; Karadayi N
    Diagn Pathol; 2010 Feb; 5():13. PubMed ID: 20167054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Endometrial carcinomas and precursor lesions--new aspects].
    Schmidt D
    Pathologe; 2009 Jul; 30(4):261-7. PubMed ID: 19495762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance and diagnostic value of PTEN and p53 expression in endometrial carcinoma. A retrospective clinicopathological and immunohistochemical study.
    Daniilidou K; Frangou-Plemenou M; Grammatikakis J; Grigoriou O; Vitoratos N; Kondi-Pafiti A
    J BUON; 2013; 18(1):195-201. PubMed ID: 23613406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
    Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
    Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.
    Soslow RA; Shen PU; Chung MH; Isacson C
    Int J Gynecol Pathol; 1998 Apr; 17(2):129-34. PubMed ID: 9553809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis.
    Riethdorf L; Begemann C; Riethdorf S; Milde-Langosch K; Löning T
    Virchows Arch; 1996 Apr; 428(1):47-51. PubMed ID: 8646368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.